Anji Pharmaceuticals Inc.

États‑Unis d’Amérique

 
Quantité totale PI 34
Rang # Quantité totale PI 42 274
Note d'activité PI 2/5.0    15
Rang # Activité PI 57 466

Brevets

Marques

25 0
7 0
2 0
0
 
Dernier brevet 2025 - Apoe mimetic peptides and higher...
Premier brevet 2012 - Chemosensory receptor ligand-bas...

Derniers inventions, produits et services

2022 Invention Methods and compositions for treating sepsis. Provided herein are methods and compositions relat...
Invention Methods and compositions for treating sepsis. Provided herein are methods and compositions relate...
2021 Invention Biguanide compositions and methods of treating metabolic disorders. Provided herein are methods f...
2019 Invention Compositions and methods for treating metabolic disorders. Compositions and methods for improvin...
Invention Compositions and methods for treating pancreatitis. The present disclosure provides methods relat...
Invention Compositions and methods for treating severe constipation. The present disclosure provides method...
Invention Compositions and methods for treating metabolic disorders. Methods for improving the gastrointest...
2018 Invention Chemosensory receptor ligand-based therapies. Provided herein are methods for treating conditions...
2017 Invention Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk....
Invention Apoe mimetic peptides and higher potency to clear plasma cholesterol. Disclosed are synthetic apo...
2015 Invention Apoe mimetic peptides and higher potency to clear plasma cholesterol. Discosed are synthetic apol...
2014 Invention Delayed-release composition comprising biguanide. Compositions and methods for improving the phar...
2013 Invention Compositions and methods of treating metabolic disorders. Methods for improving the gastrointesti...